Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357-Reference-Cited by-同舟云学术

Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357

Published:2020-10-19 Issue:1 Volume:5 Page:
ISSN:2059-3635
Container-title:Signal Transduction and Targeted Therapy
language:en
Short-container-title:Sig Transduct Target Ther

Author:

Liu Liang,Gao Quanli,Jiang Jingting,Zhang Junping,Song Xin,Cui Jiuwei,Ye Yunbin,Wang Zhiyu,Zhang Xinwei,Ren Xiubao

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics

Link

https://www.nature.com/articles/s41392-020-00337-x.pdf

Reference5 articles.

1. Liu, L. et al. Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma. Clin. Cancer Res. 18, 1751–1759 (2012).

2. Li, R. et al. Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study. Cancer Immunol. Immunother. 61, 2125–2133 (2012).

3. Amaravadi, R. K. Autophagy in tumor immunity. Science 334, 1501–1502 (2011).

4. Yang, L. et al. Cytokine-induced killer cells modulates resistance to cisplatin in the A549/DDP cell line. J. Cancer 8, 3287–3295 (2017).

5. Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat. Med. 25, 1251–1259 (2019).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial;Signal Transduction and Targeted Therapy;2024-04-03

2. Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy;Cancer Immunology, Immunotherapy;2024-01-27

3. Automatic coronary artery segmentation of CCTA images using UNet with a local contextual transformer;Frontiers in Physiology;2023-08-22

4. A Phase IB Trial of Autologous Cytokine‐Induced Killer Cells in Combination with Sintilimab, Monoclonal Antibody Against Programmed Cell Death‐1, plus Chemotherapy in Patients with Advanced Non‐Small‐Cell Lung Cancer;Clinical Lung Cancer;2022-12

5. Rational pemetrexed combined with CIK therapy plus anti-PD-1 mAbs administration sequence will effectively promote the efficacy of CIK therapy in non-small cell lung cancer;Cancer Gene Therapy;2022-11-09